Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk.
about
Chronotype and breast cancer risk in a cohort of US nursesThe circadian gene NPAS2, a putative tumor suppressor, is involved in DNA damage responseCLOCK in breast tumorigenesis: genetic, epigenetic, and transcriptional profiling analysesCircadian systems biology: When time mattersElectric light, particularly at night, disrupts human circadian rhythmicity: is that a problem?Circadian clocks and breast cancerDoes current scientific evidence support a link between light at night and breast cancer among female night-shift nurses? Review of evidence and implications for occupational and environmental health nursesCircadian genes and breast cancer susceptibility in rotating shift workersCircadian Rhythm Disruption in Cancer BiologyTesting the circadian gene hypothesis in prostate cancer: a population-based case-control study.Genetic variation of clock genes and cancer risk: a field synopsis and meta-analysisShift work, jet lag, and female reproductionMeasuring serum melatonin in epidemiologic studies.Circadian gene variants in cancer.Diversity of human clock genotypes and consequences.Circadian disruption, Per3, and human cytokine secretion.Circadian disruption and remedial interventions: effects and interventions for jet lag for athletic peak performance.Mutual antagonism between circadian protein period 2 and hepatitis C virus replication in hepatocytes.The circadian gene NPAS2 is a novel prognostic biomarker for breast cancerRetinoic acid-related orphan receptor γ directly regulates neuronal PAS domain protein 2 transcription in vivo.Functional polymorphisms in the NPAS2 gene are associated with overall survival in transcatheter arterial chemoembolization-treated hepatocellular carcinoma patients.Disrupting the circadian clock: gene-specific effects on aging, cancer, and other phenotypes.The core circadian gene Cryptochrome 2 influences breast cancer risk, possibly by mediating hormone signalingClock-cancer connection in non-Hodgkin's lymphoma: a genetic association study and pathway analysis of the circadian gene cryptochrome 2.Cancer-related transcriptional targets of the circadian gene NPAS2 identified by genome-wide ChIP-on-chip analysis.Current evidence on the relationship between two common polymorphisms in NPAS2 gene and cancer risk.Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC).RORα, a potential tumor suppressor and therapeutic target of breast cancer.Evolutionary balancing is critical for correctly forecasting disease-associated amino acid variants.The role of circadian rhythm in breast cancerDemographic history and adaptation account for clock gene diversity in humansThe Nightingale study: rationale, study design and baseline characteristics of a prospective cohort study on shift work and breast cancer risk among nurses.Circadian rhythms and cancer.Melatonin, the circadian multioscillator system and health: the need for detailed analyses of peripheral melatonin signaling.Circadian clock disruptions and the risk of cancer.Watching the clock: endoplasmic reticulum-mediated control of circadian rhythms in cancer.Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia.Aberrant DNA methylation of miR-219 promoter in long-term night shiftworkers.Clock genes and cancer.State of the evidence 2017: an update on the connection between breast cancer and the environment
P2860
Q23911252-E2962515-F171-4FDA-A33F-658E44EDE509Q24316756-946582AE-66EE-4EB8-9A33-B444189A8474Q24635191-5F94492D-5F88-41A4-B1CD-7AA97026E22BQ26796457-33E3BC27-D90D-4AB3-8866-B463A7BEC3B4Q26830662-90A562BF-7C3E-4DA4-927E-C0D5D940250BQ28077656-D340AEEC-33E0-4F9E-837F-780759F7E348Q28383241-97168A44-FB49-4C1E-8DFE-1E3DC9A9FC68Q28387050-E6BDBE76-5105-4D39-B22B-157738E8FAA4Q28972554-C4027DAA-2862-420E-99C2-20AAC430C927Q30497028-B8625BAD-6EA4-431A-A524-E5708A365DBAQ33618941-F8A7DF60-5FF4-4F49-85A3-844792B46772Q33712876-4849FD3D-CC7B-41C7-9193-91A8436B7726Q33798169-16239676-FE48-45FF-9645-806DDC4D9814Q34127839-9A0726A9-39E2-4FDD-BF93-3B372DF64451Q34214140-595CD15E-4EE2-478E-AEFD-7DB099AB45DAQ34222534-A3EF2293-8290-4B80-BAB7-F6F483ED4E36Q34251396-EFAB27F0-2CAD-4DFC-AFEA-976178127A39Q34339814-6BC1065B-9557-462B-A094-EFB12236BD6BQ34995277-2B8FCD61-EE9D-4B96-8688-740CD7AA9226Q35040936-5421839D-A1FD-4A0D-9B6F-E9386CA42F24Q35051865-84649ED9-A0BD-48AE-8F2C-AE665E3AE307Q35166095-5BAEBB6C-3F11-48EB-B66C-9AEE64527503Q35220012-310299B4-1F11-47C2-9745-F2C643365EA8Q35220037-C3E27118-24C2-47CE-AC00-0C03DD255788Q35238035-B0317C42-CBA3-4845-9FDE-1778894FB1F4Q35870703-4587BB73-F652-4570-8465-1087BD42A3E1Q36490507-D22A8586-231A-491D-B8B5-E653798619A4Q36538295-C5291A5A-AEE4-4D65-AAEC-AA5B639A788FQ36830862-A708A39D-4FE7-4F6F-99D8-6AAF238EC9E2Q37118219-94E524BF-73ED-41DD-A77C-343C4E654AF7Q37168621-857D361E-0C04-4DE4-AE96-7B3C01653B41Q37624106-9FFCE52F-5507-4D50-9653-EEE1C74BA8AFQ37710946-936830A4-89D0-4CD2-B682-21B3D9895A36Q37950409-9D203AD3-B618-49E1-BE9D-E6AA6B8F667CQ38052599-3A3584D6-E0B5-4F30-A350-E45174ED181DQ38184659-80B0B504-8F06-434A-A4AF-9CDE8443C797Q38683029-AB0BA249-8FAD-4509-BEEE-D53DCBFED219Q39132762-29FB2ADF-C967-4F7B-9EA5-9F2DD09E54D9Q39757222-8AC02FE6-FEF4-4CF8-997D-83745B74CB76Q41595188-F764553A-6BCD-42C5-AFFF-925F02E6D359
P2860
Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk.
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk.
@ast
Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk.
@en
Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk.
@nl
type
label
Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk.
@ast
Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk.
@en
Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk.
@nl
prefLabel
Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk.
@ast
Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk.
@en
Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk.
@nl
P2093
P2860
P1476
Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk.
@en
P2093
Aaron Hoffman
Derek Leaderer
Heather N Brown
Richard G Stevens
Theodore Holford
Tongzhang Zheng
Yawei Zhang
P2860
P2888
P304
P356
10.1007/S10549-007-9565-0
P407
P577
2007-04-24T00:00:00Z
P5875
P6179
1027964413